Navigation Links
Following the traces of lung cancer
Date:6/10/2011

This release is available in Spanish.

Surgeon Naia Uribe-Etxebarria has used a radioactive substance which, injected into a lung tumour, enables the detection of the path that the carcinoma intends to take in order to propagate itself. Concretely she applied technetium 99 in resectable non-small cell lung cancers (NSCLC) at an early stage (I or II), and in an intraoperative manner. Thanks to this, she detected with precision the sentinel node (SNOL); the primary node or ganglion of cells to receive lymphatic drainage from the tumour and, thus, most probably the one that will be affected by the tumour and give rise to its propagation. Her PhD thesis, defended at the University of the Basque Country (UPV/EHU), is entitled Utility of the intraoperative study of the sentinel node with technetium 99 for the staging of non-small cell lung carcinoma.

80 % of lung cancers are of the NSCLC type, of which 25-30 % are at an early stage (I or II). In these cases, surgical resection is the most effective treatment. Concretely, patients are usually subjected to anatomical resection of the pulmonary lobe or of the whole lung, together with a ganglionary dissection. This dissection helps to define the extension and seriousness (stage) of the cancer and decide on the postoperative treatment to be carried out, given that the lymphatic ganglia being affected or not is highly indicative of the progress of the cancer.

48 patients at the Cruces hospital

With regard to this, a biopsy of the sentinel node is a standard technique for determining the ganglionary stage of breast cancer or melanoma, but neither this nor tinctures are effective against lung cancer. Previous research showed that the radiotracer technique is the most effective in this case, and Ms Uribe-Etxebarria opted concretely for technetium 99 colloidal sulphate.

The research was carried out on 48 patients at the Cruces Hospital in Barakaldo (in the Basque province of Bizkaia and near Bilbao), who were injected with a dose of 0.25 millicuries within the tumour, divided into its four quadrants. After ten minutes, the radiation of the tumour and the intrathoracic ganglionary stages were measured with a manual gamma radiation counter. Migration of the radioisotope was deemed satisfactory when the radiation was thrice that marked in the primary tumour. Then, the usual operation was carried out, including tumour extraction, ganglionary sampling and recommended grade of extirpation of ganglia, depending on the case. Subsequently, gamma measurement was undertaken on these samples outside the organism. Sentinel nodes are considered to be those which, once again, showed radiation was thrice that of the base value, as this radioactivity shows the path traced by the substance and, it is thus deduced, by the disease.

Positive results of over 90 %

The results show that identification of the lung sentinel node is possible with the use of radioisotopes in an intraoperative manner. Sentinel nodes were identified in 100 % of cases, while the sensitivity, precision and negative predictive value of the technique gave values close to or greater than 90 %. There was a rate of negative false values of 11.76 %; i.e. there were cases in which radioactivity was not detected in a zone in which there was, in fact, a sentinel node. It should also be pointed out that sentinel nodes and lymphatic nodes with greatest risk of metastasis are those located near the tumour. Moreover, there may be cases in which there is more than one sentinel node (in two of the 48 cases, two were found).

Ms Uribe-Etxebarria concludes that the technique studied enhances the ganglionary staging of the patients with resectable non-small cell lung cancers (NSCLC). Detecting the sentinel node provides clues to the affected zone. This enables the pathologist to focus on a smaller number of ganglia, and carry out the pertinent techniques on these for the precise diagnosis of micrometastasis and isolated tumour cells. Moreover, residual radioactivity after resection can detect small ganglia which otherwise may go unnoticed.

Nevertheless, the researcher also specifies that this technique has certain limitations. For example, as regards identifying lymphatic ganglia close to the tumour, as the recording of the probe in this zone is very affected by the recording of the tumour itself (the shine through effect). It would be impossible to measure separately the radioactivity of the intralobular ganglia adjoining the tumour. That is why the two false negatives mentioned above appeared.


'/>"/>

Contact: Amaia Portugal
a.portugal@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Related medicine news :

1. PolicyLink CEO Angela Glover Blackwell Released the Following Statement on First Lady Michelle Obamas Childhood Obesity Initiative
2. Connecticut Board Considers Warning About Risk Of Stroke Following Chiropractic Neck Manipulation
3. Study supports alternative anti-seizure medication following acute brain injury
4. International Medical Corps on the Ground in Chile, Following 8.8-Magnitude Earthquake
5. Long Term Care Insurance Leader Seeks 320 New Agents in 2010, Following Strong 2009 Growth
6. Poor More Likely to Die Following Heart Surgery
7. New Study Identifies Cause of Severe Disequilibrium and Significant Memory Loss Following Stapedectomy Surgery
8. ShelterBox Aid en route to Mexico Following Earthquake
9. Patient-physician compatibility increases odds of following doctors orders
10. Lottery game helps to assess brain damage following stroke
11. Falls and follow-ups: Medical attention following a fall critical to senior health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
(Date:6/24/2016)... ... , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys ... peers for this recognition are considered among the top 2 percent of lawyers practicing ... members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. ...
(Date:6/24/2016)... TX (PRWEB) , ... June 24, 2016 , ... People ... part in Genome magazine’s Code Talker Award, an essay contest in which patients and ... an award to be presented at the 2016 National Society of Genetic Counselors (NSGC) ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Frederick area economy by obtaining investment capital for emerging technology companies. ... years that have already resulted in more than a million dollars of capital ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... supporting the upcoming 2016 Miss Arizona pageant as its official Medspa Sponsor. Dr. ... Tempe, Mesa, and Chandler, Arizona. , Dr. Olson says the decision to ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... , June 23, 2016 , ... Thursday, July 7, 2016 , , , , LOCATION: , ... , , , , EXPERT PANELISTS:  , , , Frost ... Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh ... The global pharmaceutical industry is witnessing an exceptional era. Several ...
Breaking Medicine Technology: